Synapse - Raajit Rampal

Results (338)

The addition of radiation therapy to initial treatment for extramedullary acute myeloid leukemia does not offer a survival benefit when added to chemotherapy

Meeting Abstract

Feller, F. M.; Patel, M.; Devlin, S. M.; Maloy, M.; Tallman, M. S.; Perales, M. A.; Rampal, R. K.
Blood (2014)

Fulltext@MSK | Save

Unraveling the molecular basis of Langerhans and non-Langerhans cell histiocytic neoplasms through whole exome sequencing

Meeting Abstract

Durham, B.; Ma, J.; Kim, E.; Choi, J. K.; Campbell, P.; Estrada-Veras, J.; Walsh, M. P.; Lacouture, M. E.; Chung, Y. R.; Nakitandwe, J.; more...
Blood (2014)

Fulltext@MSK | Save

Utility of combined DNA and RNA next generation sequencing in leukemias for identification of prognostic and therapeutically relevant genomic alterations in clinical practice

Meeting Abstract

Coombs, C. C.; Viny, A. D.; He, J.; Kobos, R.; Lipson, D.; Shukla, N.; Knapp, K. M.; Otto, G.; Abdel-Wahab, O.; Stein, E. M.; more...
Blood (2014)

Fulltext@MSK | Save

DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia

Journal Article

Rampal, R.; Alkalin, A.; Madzo, J.; Vasanthakumar, A.; Pronier, E.; Patel, J.; Li, Y.; Ahn, J.; Abdel-Wahab, O.; Shih, A.; more...
Cell Reports (2014)

Fulltext@MSK | Save

Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasms

Journal Article

Rampal, R.; Ahn, J.; Abdel-Wahab, O.; Nahas, M.; Wang, K.; Lipson, D.; Otto, G. A.; Yelensky, R.; Hricik, T.; McKenney, A. S.; more...
Proceedings of the National Academy of Sciences of the United States of America (2014)

Fulltext@MSK | Save

Integrated genomic analysis illustrates the central role of jak-stat pathway activation in myeloproliferative neoplasm pathogenesis

Meeting Abstract

Rampal, R.; Al-Shahrour, F.; Abdel-Wahab, O.; Patel, J.; Brunel, J. P.; Mermel, C.; Bass, A.; Pretz, J.; Ahn, J.; Hricik, T.; more...
Haematologica (2014)

Fulltext@MSK | Save

Treatment with radiation, chemotherapy, or both demonstrates similar outcomes in patients with isolated myeloid sarcoma that may not be different than de novo acute myeloid leukemia